Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Cipla
Colorcon
Citi
Teva
Queensland Health

Generated: September 19, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,161,914

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,161,914 protect, and when does it expire?

Patent 9,161,914 protects NAFTIN and is included in one NDA.

This patent has three patent family members in three countries.

Summary for Patent: 9,161,914
Title:Topical compositions and methods for making and using same
Abstract: The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
Inventor(s): Hardas; Bhushan (Summerville, NC), Dalton; Donna (High Point, NC)
Assignee: Merz Pharmaceuticals, LLC (Raleigh, NC)
Application Number:14/297,293
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,161,914
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 9,161,914

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sebela Ireland Ltd NAFTIN naftifine hydrochloride GEL;TOPICAL 204286-001 Jun 27, 2013 AB RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT OF FUNGAL INFECTIONS ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Julphar
Express Scripts
QuintilesIMS
Fish and Richardson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.